Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology
Myasthenia gravis (MG) is a prototypical autoantibody mediated disease. The autoantibodies in MG target structures within the neuromuscular junction (NMJ), thus affecting neuromuscular transmission. The major disease subtypes of autoimmune MG are defined by their antigenic target. The most common ta...
Main Authors: | Miriam L. Fichtner, Ruoyi Jiang, Aoibh Bourke, Richard J. Nowak, Kevin C. O’Connor |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.00776/full |
Similar Items
-
Management of Juvenile Myasthenia Gravis
by: Karen O'Connell, et al.
Published: (2020-07-01) -
New Approaches to Targeting B Cells for Myasthenia Gravis Therapy
by: Ruksana Huda
Published: (2020-02-01) -
Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations
by: Laura Dresser, et al.
Published: (2021-05-01) -
Myasthenia Gravis Can Have Consequences for Pregnancy and the Developing Child
by: Nils Erik Gilhus, et al.
Published: (2020-06-01) -
IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
by: E. D. Gasymly
Published: (2018-06-01)